GO:0035478 chylomicron binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035478 chylomicron binding is a molecular function defined as binding to a chylomicron, a large triglyceride- and cholesterol-rich lipoprotein particle (75-1200 nm) whose protein coat includes one molecule of apolipoprotein B-48 and may include APOAs, APOCs and APOE.
• Chylomicron binding is central to intestinal lipid absorption, because chylomicrons must dock onto endothelial and hepatic surfaces before their lipids can be taken up [3,6].
• Endothelial cells in culture bind chylomicrons and take up their lipid in a saturable, protein-dependent manner, establishing chylomicron binding as a measurable cellular function.
• Intestinal lipid-binding proteins sense fatty acids and help route them toward chylomicron assembly and secretion, linking binding events to whole-body lipid handling.
• Chylomicron binding is physiologically important beyond nutrition: chylomicron remnants compete with malaria sporozoites for hepatic binding sites, implicating this function in host-pathogen interactions.
• Because chylomicron binding depends on surface apolipoproteins and receptors, it is studied with CRISPR knockout, point-mutation, knock-in and overexpression models combined with lipid flux and imaging assays.
Description
Chylomicron binding (GO:0035478) is the molecular function of selectively and non-covalently interacting with a chylomicron, the large lipoprotein particle that carries dietary triglycerides and cholesterol from the intestine into the circulation [3,6]. Chylomicrons are 75-1200 nm particles with a neutral lipid core and a surface coat that contains one molecule of apolipoprotein B-48 and may also contain APOAs, APOCs and APOE. Because these particles are too large to cross endothelial barriers passively, their fate depends on binding events at cell surfaces, including endothelial cells and hepatocytes [3,6,7]. Researchers study chylomicron binding to understand how dietary fat is absorbed, how postprandial lipemia is cleared, and how defects in lipoprotein recognition contribute to metabolic disease [1,3].
chylomicron binding At A Glance
| GO ID | GO:0035478 |
|---|---|
| GO term | chylomicron binding |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Binding to a chylomicron, a large lipoprotein particle (diameter 75-1200 nm) composed of a central core of triglycerides and cholesterol surrounded by a protein-phospholipid coating; the proteins include one molecule of apolipoprotein B-48 and may include APOAs, APOCs and APOE. |
| Major function | Recognition and docking of chylomicrons at cell surfaces, enabling lipid uptake and clearance [3,6]. |
| Particle size | 75-1200 nm diameter |
| Core composition | Triglycerides and cholesterol |
| Surface composition | Protein-phospholipid coating with APOB-48 and possibly APOAs, APOCs, APOE |
| Related biology | Intestinal lipid absorption, postprandial lipemia, hepatic remnant clearance [1,3,7] |
What Is GO:0035478?
In the Gene Ontology, GO:0035478 chylomicron binding is a molecular function: the binding to a chylomicron, a large lipoprotein particle (diameter 75-1200 nm) composed of a central core of triglycerides and cholesterol surrounded by a protein-phospholipid coating. The proteins include one molecule of apolipoprotein B-48 and may include a variety of apolipoproteins, including APOAs, APOCs and APOE. In practical terms, any protein that physically associates with the chylomicron surface or core, whether a receptor, a lipid-transfer protein or a structural apolipoprotein, can carry this annotation.
Why Is chylomicron binding Important in Cell Biology?
Chylomicron binding matters because it is the first committed step that allows dietary fat to be delivered to tissues. Endothelial cells bind chylomicrons and take up their lipid in a saturable manner, so the binding interaction gates lipid transfer from the gut to muscle and adipose tissue. In parallel, intestinal lipid-binding proteins that sense fatty acids coordinate chylomicron assembly and secretion, coupling binding and transport to whole-body energy balance. Chylomicron binding also has clinical and infectious-disease relevance: chylomicron remnants compete with malaria sporozoites for binding sites in the liver, showing that this molecular function can influence pathogen entry. Finally, because chylomicrons regulate lacteal permeability and intestinal lipid absorption, binding events at the lymphatic endothelium are now recognized as active regulators of fat uptake rather than passive diffusion.
• Defines the molecular recognition step for dietary fat delivery from intestine to peripheral tissues [3,6].
• Enables saturable, protein-dependent lipid uptake by endothelial cells in culture.
• Links fatty-acid sensing by intestinal lipid-binding proteins to chylomicron synthesis and secretion.
• Contributes to postprandial lipemia and chylomicron remnant clearance by the liver [1,7].
• Provides a mechanistic handle on lacteal permeability and intestinal lipid absorption.
• Explains why chylomicron remnants and malaria sporozoites compete for hepatic binding sites.
• Supports research on lipid-soluble micronutrient transport, including vitamin E and retinoids handled by lipid-binding proteins [4,5,8].
• Offers a target for CRISPR screens aimed at identifying novel chylomicron receptors and trafficking factors [3,6].
Molecular Mechanism of chylomicron binding
Chylomicron recognition at the cell surface
In simple terms: Cells first grab chylomicrons with surface proteins before taking in their fat.
Chylomicron binding begins when a cell-surface protein recognizes the particle's protein-phospholipid coat. Endothelial cells in culture bind chylomicrons and take up their lipid in a saturable fashion, indicating a finite number of binding sites and a receptor-like interaction rather than nonspecific adsorption. Because the chylomicron surface contains APOB-48 and may contain APOAs, APOCs and APOE, these apolipoproteins are candidate recognition determinants for binding proteins [3,6].
Fatty-acid sensing and chylomicron assembly
In simple terms: Inside the gut cell, proteins sense incoming fat and help package it into chylomicrons.
Intestinal lipid-binding proteins translate fatty-acid sensing into chylomicron synthesis, so the abundance and lipid occupancy of these proteins influence how many particles are available for binding. This step couples dietary lipid availability to the production of chylomicrons that subsequently engage surface binding sites.
Binding at the lymphatic endothelium
In simple terms: Chylomicrons interact with lymphatic vessels and change how leaky they are.
Chylomicrons regulate lacteal permeability and intestinal lipid absorption, meaning that binding interactions at the lymphatic endothelium actively modulate the route by which absorbed fat enters the lymph. This positions chylomicron binding as a regulatory event in lipid absorption, not merely a passive transport step.
Hepatic recognition and remnant competition
In simple terms: The liver has binding sites that chylomicron remnants share with other particles.
Chylomicron remnants compete with malaria sporozoites for binding sites in the liver, demonstrating that hepatic chylomicron binding sites are shared and saturable. This competition provides functional evidence that chylomicron binding is a discrete, receptor-mediated molecular function with pathophysiological consequences.
Lipid uptake following binding
In simple terms: Once bound, the fat carried by chylomicrons is transferred into the cell.
Binding is functionally coupled to lipid uptake: endothelial cells that bind chylomicrons also take up their lipid, linking the molecular function of binding to downstream lipid delivery. Lipid-binding proteins involved in vitamin E and retinoid handling further illustrate how lipid cargo and binding proteins cooperate in transport processes [4,5,8].
Key Genes Involved in GO:0035478 chylomicron binding
The following genes and proteins are directly implicated in chylomicron biology, lipid sensing or chylomicron binding-related transport, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| APOB | Structural apolipoprotein of chylomicrons; APOB-48 is the defining protein of the chylomicron coat | Core marker of chylomicron identity and binding target [3,6] |
| APOA1 | Exchangeable apolipoprotein that can associate with chylomicron surfaces | Candidate surface ligand for chylomicron-binding proteins |
| APOA4 | Intestinal apolipoprotein involved in chylomicron assembly and metabolism | Links intestinal lipid handling to chylomicron binding [1,3] |
| APOA5 | Modulates triglyceride-rich lipoprotein metabolism | Candidate regulator of chylomicron clearance and binding |
| APOC2 | Apolipoprotein component of triglyceride-rich lipoproteins | Surface component that may influence chylomicron recognition |
| APOC3 | Apolipoprotein that modulates triglyceride-rich lipoprotein catabolism | Relevant to postprandial chylomicron handling |
| APOE | Exchangeable apolipoprotein mediating remnant recognition | Key ligand for hepatic chylomicron remnant binding [3,7] |
| CD36 | Fatty acid translocase and lipid sensor | Fatty acid signal transduction relevant to chylomicron lipid uptake |
| FABP1 | Intestinal fatty-acid-binding protein | Fatty-acid sensing linked to chylomicron synthesis |
| FABP2 | Intestinal fatty-acid-binding protein | Contributes to intestinal lipid trafficking and chylomicron assembly |
| CRABP1 | Cellular retinoic acid-binding protein | Example of lipid-binding protein family relevant to lipid transport [5,8] |
| CRABP2 | Cellular retinoic acid-binding protein | Lipid-binding protein family member [5,8] |
| TTPA | Tocopherol transfer protein, a lipid-binding protein for vitamin E | Illustrates lipid-binding protein biology relevant to lipoprotein transport |
| LRP1 | Endocytic receptor for remnant lipoproteins | Candidate hepatic chylomicron remnant binding receptor |
| SCARB1 | Scavenger receptor class B member 1 | Lipoprotein receptor relevant to chylomicron lipid uptake |
| LPL | Lipoprotein lipase that hydrolyzes chylomicron triglycerides | Acts on bound chylomicrons at the endothelium [3,6] |
| GPIHBP1 | Endothelial platform for lipoprotein lipase | Endothelial docking factor for triglyceride-rich lipoproteins |
| VEGFA | Regulator of lacteal and endothelial permeability | Linked to chylomicron-regulated lacteal permeability |
How Is chylomicron binding Regulated?
Chylomicron binding is regulated at several levels. Fatty-acid sensing by intestinal lipid-binding proteins controls the assembly and secretion of chylomicrons, thereby determining how much ligand is available for binding. At the endothelium, chylomicrons themselves regulate lacteal permeability, creating a feedback loop in which binding influences the accessibility of the absorption route. Hepatic binding sites are shared and saturable, as shown by competition between chylomicron remnants and malaria sporozoites, indicating that occupancy and ligand competition regulate this function in vivo. Lipid-binding proteins involved in vitamin E and retinoid transport further modulate the lipid cargo environment that accompanies chylomicron binding [4,5,8].
chylomicron binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| APOB | Chylomicron assembly and triglyceride-rich lipoprotein metabolism | APOB knockout or point-mutation intestinal cell model |
| APOE | Chylomicron remnant clearance and hepatic binding | APOE knockout hepatocyte model with remnant binding assay |
| CD36 | Fatty acid signal transduction and lipid uptake | CD36 knockout endothelial or intestinal cell model |
| FABP1 | Intestinal fatty-acid sensing and chylomicron synthesis | FABP1 knockout enterocyte model with lipid flux assay |
| LRP1 | Hepatic remnant lipoprotein binding and pathogen competition | LRP1 knockout hepatocyte model with sporozoite competition assay |
Metabolic dyslipidemia and postprandial lipemia
Because chylomicron binding gates the delivery of dietary fat, defects in recognition or binding contribute to impaired postprandial lipid clearance and triglyceride-rich lipoprotein accumulation [1,3]. Intestinal lipid-binding proteins that sense fatty acids and drive chylomicron synthesis are directly relevant to these metabolic phenotypes.
Malaria infection and hepatic sporozoite entry
Chylomicron remnants compete with malaria sporozoites for binding sites in the liver, linking chylomicron binding to host-pathogen competition and suggesting that hepatic lipoprotein binding sites can influence infection.
Lymphatic and intestinal lipid absorption disorders
Chylomicrons regulate lacteal permeability and intestinal lipid absorption, so altered chylomicron binding at the lymphatic endothelium may contribute to malabsorption or abnormal fat trafficking.
Lipid-soluble micronutrient transport
Lipid-binding proteins involved in vitamin E and retinoid handling participate in the broader lipid transport system that includes chylomicrons, connecting chylomicron binding biology to micronutrient status [4,5,8].
From chylomicron binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for chylomicron binding? | CRISPR knockout cell line plus fluorescent chylomicron binding assay |
| Does a specific residue mediate chylomicron recognition? | Point-mutation knock-in of the candidate residue |
| Can a tagged protein be used to visualize chylomicron binding sites? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression increase chylomicron binding and lipid uptake? | Overexpression cell model with lipid uptake readout |
| Which genes regulate chylomicron binding at the endothelium? | CRISPR library screening in endothelial cells |
| How does chylomicron binding alter lacteal permeability? | In vivo or organoid model with permeability imaging |
How to Study the chylomicron binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Labeled chylomicron binding assay | Direct binding and saturability | Quantify chylomicron binding to endothelial cells |
| Lipid uptake assay | Cellular lipid internalization after binding | Link binding to functional lipid delivery |
| Fatty-acid sensing assay | Intestinal lipid-binding protein response | Connect fatty-acid sensing to chylomicron synthesis |
| Lacteal permeability imaging | Lymphatic endothelial barrier function | Test chylomicron effects on absorption |
| Competition binding assay | Shared versus specific binding sites | Probe hepatic remnant and sporozoite competition |
| CRISPR knockout screening | Gene requirement for binding | Identify novel chylomicron binding factors [3,6] |
| Proteomics of bound fractions | Protein composition of binding complexes | Discover surface receptors and apolipoproteins [3,6] |
| Lipid-binding protein profiling | Expression of lipid carrier proteins | Contextualize binding within lipid transport networks [4,5,8] |
Fluorescent and radiolabeled chylomicron binding assays
Binding of chylomicrons to cells can be measured directly using labeled particles, as established by classic endothelial cell binding and lipid uptake experiments. These assays quantify saturability, affinity and competition, and are the primary readout for GO:0035478.
Lipid flux and fatty-acid sensing assays
Because intestinal lipid-binding proteins couple fatty-acid sensing to chylomicron synthesis, lipid flux assays and fatty-acid uptake measurements provide functional context for binding studies [1,2].
Endothelial permeability and lacteal imaging
Chylomicrons regulate lacteal permeability, so imaging of lymphatic endothelial permeability in response to chylomicrons is a key method for studying the physiological consequences of binding.
Competition and hepatic binding assays
Competition experiments between chylomicron remnants and malaria sporozoites for hepatic binding sites provide a functional method to probe shared binding sites and their specificity.
How CRISPR Can Be Used to Study GO:0035478 chylomicron binding
Knockout
CRISPR knockout of candidate genes such as APOB, APOE, CD36, FABP1 or LRP1 can test whether a gene is required for chylomicron binding and downstream lipid uptake [1,2,3,6,7]. Knockout endothelial or hepatic cells are then challenged with labeled chylomicrons to measure loss of binding.
Point Mutation
Point-mutation models allow residue-level dissection of chylomicron recognition, for example by mutating apolipoprotein surface residues or receptor ligand-binding domains and measuring binding affinity [3,6,7].
Knock-in
Tagged knock-in of endogenous genes enables visualization and purification of chylomicron binding complexes, helping map where and when binding occurs at the endothelium and liver [3,6].
Overexpression
Overexpression of candidate receptors or apolipoproteins can test sufficiency for chylomicron binding and lipid uptake, complementing loss-of-function knockout experiments [1,3,6].
How EDITGENE Supports chylomicron binding Research
Researchers studying chylomicron binding-related genes often need to determine whether a candidate gene is causally involved in particle recognition, lipid uptake or lymphatic permeability, rather than merely correlated with these phenotypes. EDITGENE provides the CRISPR cell models and screening services required to move from candidate lists to mechanistic evidence.
Contact EDITGENE today to design your custom CRISPR model for chylomicron binding research.
Frequently Asked Questions About chylomicron binding
What is chylomicron binding (GO:0035478)?
Chylomicron binding is a molecular function defined as binding to a chylomicron, a large lipoprotein particle (75-1200 nm) with a triglyceride and cholesterol core and a protein-phospholipid coat containing APOB-48 and possibly APOAs, APOCs and APOE.
What genes are involved in chylomicron binding?
Genes implicated in chylomicron biology and binding-related transport include APOB, APOA1, APOA4, APOA5, APOC2, APOC3, APOE, CD36, FABP1, FABP2, LRP1, SCARB1, LPL and GPIHBP1 [1,2,3,6,7].
Why is chylomicron binding important for lipid absorption?
Chylomicrons must bind to endothelial and hepatic surfaces before their lipids can be taken up, and chylomicrons also regulate lacteal permeability and intestinal lipid absorption [3,6].
Which cells bind chylomicrons?
Endothelial cells in culture bind chylomicrons and take up their lipid in a saturable manner, and hepatic binding sites for chylomicron remnants have also been demonstrated [6,7].
How is chylomicron binding measured experimentally?
Labeled chylomicron binding assays, lipid uptake assays, competition experiments and lacteal permeability imaging are standard approaches [3,6,7].
Is chylomicron binding related to malaria infection?
Yes, chylomicron remnants compete with malaria sporozoites for binding sites in the liver, linking this molecular function to host-pathogen competition.
What is the role of intestinal lipid-binding proteins in chylomicron binding?
Intestinal lipid-binding proteins sense fatty acids and drive chylomicron synthesis, determining how much ligand is available for binding.
Can CRISPR be used to study chylomicron binding?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models can test whether specific genes are required or sufficient for chylomicron binding and lipid uptake [1,2,3,6,7].
What is the size and composition of a chylomicron?
Chylomicrons are 75-1200 nm particles with a core of triglycerides and cholesterol and a surface protein-phospholipid coat containing APOB-48 and possibly APOAs, APOCs and APOE.
Which diseases are linked to chylomicron binding defects?
Impaired chylomicron binding and clearance are linked to postprandial lipemia and metabolic dyslipidemia, and hepatic binding sites are relevant to malaria sporozoite entry [1,3,7].
Conclusion
Chylomicron binding (GO:0035478) is a discrete molecular function that governs how the body recognizes and delivers dietary fat. From saturable endothelial binding and lipid uptake to lacteal permeability regulation and hepatic remnant competition, this function sits at the intersection of nutrition, metabolism and infection biology [3,6,7]. Intestinal lipid-binding proteins that sense fatty acids and drive chylomicron synthesis provide the upstream supply of ligand, while apolipoproteins such as APOB-48, APOE and APOCs define the particle surface that is recognized [1,3].
References
- 1. Buttet M et al.. 2014. From fatty-acid sensing to chylomicron synthesis: role of intestinal lipid-binding proteins.. Biochimie 96:37-47 PMID: 23958439
- 2. Pepino MY et al.. 2014. Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism.. Annu Rev Nutr 34:281-303 PMID: 24850384
- 3. Zarkada G et al.. 2023. Chylomicrons Regulate Lacteal Permeability and Intestinal Lipid Absorption.. Circ Res 133(4):333-349 PMID: 37462027
- 4. Mustacich DJ et al.. 2007. Vitamin E.. Vitam Horm 76:1-21 PMID: 17628169
- 5. Ong DE. 1987. Cellular retinoid-binding proteins.. Arch Dermatol 123(12):1693-1695a PMID: 2825608
- 6. Fielding CJ et al.. 1979. Characteristics of chylomicron binding and lipid uptake by endothelial cells in culture.. J Biol Chem 254(18):8861-8 PMID: 225314
- 7. Nussenzweig V. 1997. Malaria sporozoites and chylomicron remnants compete for binding sites in the liver.. Behring Inst Mitt PMID: 9303206
- 8. Okuno M et al.. 1993. [Cellular retinoid-binding proteins].. Nihon Rinsho 51(4):879-85 PMID: 8387121
